Oncology Pharma (ONPH) Stock Price, News & Analysis

Company Overview

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.

Key Stats

• Today's Range: $0.0001 to $0.0001
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.13
• Volume: 431 shs
• Average Volume: 3,561 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ONPH Stock Analysis - Frequently Asked Questions

How have ONPH shares performed this year?

Oncology Pharma's stock was trading at $0.0001 at the beginning of the year. Since then, ONPH stock has increased by 0.0% and is now trading at $0.0001.
View the best growth stocks for 2025 here.

How do I buy shares of Oncology Pharma?

Shares of ONPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Oncology Pharma own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Oncology Pharma investors own include Blue Energy (BLU), SoFi Technologies (SOFI), Ford Motor (F), NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD) and Alpha Lithium (APHLF).

Company Calendar

• Today: 5/27/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Prepackaged software
• Sub-Industry: Computer Software
• Current Symbol: OTCMKTS:ONPH
• CIK: N/A
• Web: www.oncology-pharma.com
• Phone: (415) 869-1038
• Fax: 858-385-8997
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 0.78